Background Integrated drug efficacy surveillance (iDES) was formally introduced nationally
across Thailand in fiscal year 2018 (FY2018), building on a history of drug efficacy …

Background The World Health Organization (WHO) recommends artemisinin‐based
combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria …

Emergence and spreading of antimalarial drug resistant malaria parasites are great hurdles
to combating malaria. Although approaches to investigate antimalarial drug resistance …

Background Many studies have reported high efficacy and safety of artesunate-amodiaquine
(AS-AQ) and artemether-lumefantrine (AL) when administered under direct observation in …

The aim of this narrative review is to summarise efficacy and pharmacokinetic data for
Plasmodium vivax in children. The burden of P. vivax malaria in children continues to remain …

The emergence and spread of chloroquine-resistant Plasmodium vivax have necessitated
the assessment of alternative blood schizonticidal drugs. In Vietnam, chloroquine-resistant …

Background/Aim: The aberrant regulation of erythropoietin-producing hepatocellular
carcinoma (EPH) receptors and ephrin ligands has been implicated in breast carcinoma …

Background Pyronaridine-artesunate (PA) is a registered artemisinin-based combination
therapy, potentially useful for mass drug administration campaigns. However, further data …

Background Early case detection and prompt treatment are important malaria control and
elimination strategies. However, the emergence and rapid spread of drug-resistant strains …

[eng] Malaria caused 241 million cases and 627,000 deaths worldwide in 2020,
representing one of the biggest threats for global health nowadays. The currently available …